[Efficacy and safety of biweekly nedaplatin in combination with docetaxel as second-line chemotherapy in patients with unresectable or recurrent esophageal cancer].

Tomoyuki Irino, Tomohisa Egawa, Takeshi Kenmochi, Yasuhiro Ito, Koki Mihara, Akihiko Okamura, Eiichi Eto, Yusaku Inaba, Masaaki Murakawa, Atsushi Nagashima

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of '[Efficacy and safety of biweekly nedaplatin in combination with docetaxel as second-line chemotherapy in patients with unresectable or recurrent esophageal cancer].'. Together they form a unique fingerprint.

Medicine & Life Sciences